High quality of 58-month life in lung cancer patient with brain metastases sequentially treated with gefitinib and osimertinib

Brain metastases (BMs) and bone metastases seriously affect the prognosis of lung cancer patients. How to optimize the use of existing targeted drugs is an important way to address the clinical needs of the central nervous system in the individualized treatment of non-small cell lung cancer (NSCLC)....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ying, Zhang, Xiaowen, Wang, Fang, Feng, Yan, Tang, Huaping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546288/
https://www.ncbi.nlm.nih.gov/pubmed/34722896
http://dx.doi.org/10.1515/med-2021-0379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546288/
https://www.ncbi.nlm.nih.gov/pubmed/34722896
http://dx.doi.org/10.1515/med-2021-0379

Ejemplares similares